A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection.
Michael RoshonLuciano Lemos-FilhoHolli CherevkaLaura GoldbergKristin SalottoloDavid Bar-OrPublished in: Infectious diseases and therapy (2021)
Clinicaltrials.gov identifier: NCT04606784.
Keyphrases